HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Prevention, management of health care-associated infections critical to cancer care
-
- Benefit-to-harm ratio favors mammography beginning at age 40
- Histopathologic review may aid diagnosis, treatment of pediatric unilateral retinoblastoma
- Long-term solutions sought for shortages of vital oncology drugs
- UPDATE: Supreme Court upholds Affordable Care Act
- Check the mouths of patients with low-risk myelodysplasia Harry S. Jacob, MD, DHC
- Woman presents with severe pain, elevated IOP in right eye Steven L. Williams, MD; Hugo Daniel Nano, MD; Daniel Hu, MD
- CDC: Increase efforts to reduce blood clot risk among hospitalized patients
- AYA cancer survivors at increased risk for chronic conditions, health problems
-
- Colorectal cancer risk greater among relatives of patients with serrated polyposis
- Completion rates of HPV vaccination series decreasing
- Dermatologists must better facilitate screenings of melanoma patients’ first-degree relatives
- Rituximab maintained 5-year response in a quarter of ITP patients
- Robotic-assisted prostatectomy cost significantly more compared with traditional surgery
- Addition of bevacizumab to chemotherapy doubled PFS among women with platinum-resistant ovarian cancer
- Anti-psychotic medication helps control breakthrough CINV
- Adolescent and young adult patients with high-risk ALL have poorer survival than younger patients
-
- BMI associated with colorectal cancer diagnosis in patients aged less than 50 years
- Colorectal neoplasia prevalence higher among African Americans than Hispanics
- Endoscopic eradication therapy can lead to strictures in patients with Barrett's esophagus
- Gene signature predicted spread of brain metastases in HER-2–positive patients
- Investigational BRAF inhibitor extended survival in metastatic melanoma patients
- Maintenance therapy improved PFS, increased toxicity in metastatic breast cancer
- METRIC: Investigational inhibitor improves survival in advanced melanoma
- Targeted multikinase inhibitor extends PFS for patients with treatment-resistant GISTs
-